Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,992 | $4,954 | $17,581 | $21,848 |
| - Cash | $2,395 | $3,280 | $3 | $100 |
| + Debt | $452 | $248 | $935 | $343 |
| Enterprise Value | $1,049 | $1,922 | $18,513 | $22,090 |
| Revenue | $7,982 | $5,515 | $5,618 | $1,410 |
| % Growth | 44.7% | -1.8% | 298.4% | – |
| Gross Profit | $1,653 | $1,409 | $1,062 | $430 |
| % Margin | 20.7% | 25.5% | 18.9% | 30.5% |
| EBITDA | -$3,681 | -$2,836 | -$2,075 | -$3 |
| % Margin | -46.1% | -51.4% | -36.9% | -0.2% |
| Net Income | -$3,759 | -$2,938 | -$2,118 | -$3 |
| % Margin | -47.1% | -53.3% | -37.7% | -0.2% |
| EPS Diluted | -0.52 | -0.6 | -0.29 | -0.001 |
| % Growth | 13.3% | -106.9% | -57,900% | – |
| Operating Cash Flow | -$2,932 | -$2,759 | -$2,244 | -$88 |
| Capital Expenditures | -$11 | -$15 | -$121 | -$6 |
| Free Cash Flow | -$2,943 | -$2,774 | -$2,365 | -$94 |